Helpful tips

What is the J code for Aranesp?

What is the J code for Aranesp?

Aranesp is reported with HCPCS code J0881 effective January 1, 2006.

Is there a biosimilar for Aranesp?

JCR Pharmaceuticals, together with partner Kissei Pharmaceutical, is currently developing a darbepoetin alfa biosimilar, JR-131, referencing Aranesp. Darbepoetin alfa is used to treat anemia caused by chronic kidney disease or by chemotherapy.

Is Procrit and Aranesp the same?

The differences between the two drugs are not limited to molecular structure: While Procrit is measured in units per kilogram of the patient’s weight, Aranesp is measured in micrograms per kg. There is currently no formula for direct comparison of dosages measured in units to those measured by weight.

Are Epogen and Aranesp the same?

Epoetin alfa (Retacrit, Procrit, Epogen) is a glycoprotein that stimulates red blood cell production; whereas, darbepoetin alfa (Aranesp) stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.

Is Aranesp covered by Medicare Part B?

EPO and Aranesp are covered under the Part B benefit for the treatment of anemia associated with ESRD patients who are on dialysis. Epoetin is a biologically engineered protein that stimulates the bone marrow to make new red blood cells.

What is code J0882?

J0882 is a valid 2021 HCPCS code for Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) or just “Darbepoetin alfa, esrd use” for short, used in Medical care.

Is Aranesp a biologic?

Aranesp ® Aranesp is the trade name for darbepoetin alfa. In some cases, health care professionals may use the trade name aranesp when referring to the generic drug name darbepoetin alfa. Drug Type: Darbepoetin alfa is a biologic response modifier.

Is epoetin alfa a biologic?

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

How often should Aranesp be given?

Aranesp is given every 1 to 4 weeks, depending on the condition you are treating. You may also need to take blood pressure medication. Follow your doctor’s instructions very carefully. Aranesp is injected under the skin, or given as an infusion into a vein.

Is Aranesp better than Epogen?

There are no clinically significant differences in the safety and efficacy of epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp), the two drugs most commonly used to treat anemia in cancer patients undergoing chemotherapy or radiation treatments, according to a new report by the Agency for Healthcare …

What is Aranesp prescribed for?

Aranesp may be used to treat a lower than normal number of red blood cells (anemia) if it is caused by: • Chronic kidney disease (you may or may not be on dialysis). Chemotherapy that will be used for at least two months after starting Aranesp. months. If you have a cancer that has a high chance of being cured.